Cannabis News
AI to Create New Weed Strains?
Published
1 month agoon
By
admin
Science Based Weed Strains: GSD”
After decades of writing about cannabis, I’ve become increasingly convinced that we’ve only scratched the surface of what this miraculous plant can offer humanity. While most folks are familiar with THC and CBD, the cannabis plant contains hundreds of compounds that interact with our bodies in fascinating and complex ways. We’re like children playing with blocks, just beginning to understand the intricate architecture possible when these compounds work in concert.
Think about it – there are over 100 known cannabinoids, more than 150 terpenes, and countless other bioactive compounds in cannabis. The potential combinations are staggering, and each could potentially produce unique effects. As our understanding of these mechanisms deepens, we’re approaching an era where we can design cannabis strains for specific purposes, much like a master perfumer blending scents or a pharmaceutical researcher developing targeted medications.
This isn’t just theoretical anymore. Earlier this year, I caught wind of something that perfectly illustrates this potential – a groundbreaking new strain called “Get Sh!t Done” (GSD). What caught my attention wasn’t just its clever name, but its impressive THCV content – a lesser-known cannabinoid that’s typically found in trace amounts. The developers claim they’ve created something remarkable: a strain that provides energy and focus without the traditional downsides of cannabis use like fatigue, mental fog, or the dreaded munchies.
As someone who’s watched countless strains come and go, often accompanied by grandiose marketing claims, I’ll admit I was skeptical at first. But this one’s different – it’s backed by actual clinical research and reproducible results. Let’s take a deeper look at what makes this strain so special and what it might mean for the future of cannabis development.
When Natural Natural announced they’d developed a strain containing 15-20% THCV, it raised more than a few eyebrows in the cannabis community. For context, most strains contain only trace amounts of THCV, typically less than 1%. Creating a strain with these levels while maintaining an 8-week flowering time is nothing short of revolutionary.
But what exactly makes THCV special? While its molecular structure closely resembles THC, THCV interacts with our endocannabinoid system in profoundly different ways. Think of THC as a key that fully opens a lock – in this case, the CB1 receptor in our brain. THCV, on the other hand, acts more like a dimmer switch. At lower doses, it can actually block these receptors, while at higher doses it activates them differently than THC does. This unique interaction explains why THCV doesn’t cause the typical “stoner” effects we associate with cannabis.
The real game-changer here is the clinical validation. Natural Natural didn’t just breed a high-THCV strain and call it a day – they put it to the test. In their IRB-backed study, they found some fascinating results. Users of GSD reported 20% higher energy levels compared to control groups, and perhaps most interestingly, those who consumed traditional THC-only products reported feeling fatigued approximately three times more often than the GSD group. As someone who’s written extensively about cannabis research, I can tell you that this kind of clinical validation is unfortunately rare in our industry.
Whitney Conroy from Natural Natural shared some insights with me that I found particularly intriguing. “THCV interacts with receptors in the brain differently. It is not impairing like THC. One study showed that THCV can improve response time in tests of impairment.” This challenges the traditional narrative about cannabis use and cognitive function.
What excites me most about GSD isn’t just what it does, but what it represents for the future of cannabis development. As Conroy explains, “We believe that the cannabis plant has endless opportunities… Breeding over the past 60 years has focused on THC potency. We believe it is time to move Beyond THC and bring back this diversity of chemistry to harness the power of cannabis truly.”
I couldn’t agree more. For too long, the cannabis industry has been fixated on THC percentages, treating them like the alcohol content of beer. But cannabis isn’t alcohol – it’s infinitely more complex and nuanced. GSD represents a shift toward purposeful breeding, where strains are developed not just to get users high, but to produce specific, beneficial effects.
The success of GSD suggests we’re entering a new era of cannabis development, where science, not marketing, leads the way. And if this is just the beginning, I can’t wait to see what comes next.
Having spent years observing and writing about the cannabis industry, I’ve developed some strong opinions about where we’re headed. In my view, we’re witnessing the early stages of a major transformation that will eventually split cannabis into three distinct categories: Recreational, Medical, and Industrial. While these categories technically exist today, the lines between them will become much sharper and more defined in the coming years.
The medical segment particularly fascinates me. I believe we’ll see it evolve away from the familiar “smoke your medicine” approach that currently dominates the market. Let’s be honest – while smoking flower might be enjoyable, it’s not the most efficient or precise way to deliver medical benefits. The development of strains like GSD points toward a future where medicinal cannabis more closely resembles traditional pharmaceuticals or supplements, with precise dosing and specific, targeted effects.
Industrial hemp is already carving out its own niche in the American economy, and I expect this trend to accelerate. From sustainable building materials to biodegradable plastics, the applications seem endless. But it’s the recreational market where I anticipate the most interesting developments.
The emergence of strains like GSD suggests we’re moving beyond the simple paradigm of “getting high” toward something more nuanced and purposeful. I envision a future where recreational cannabis splits into two main branches: classic recreational experiences (what we typically think of as getting high) and what I call “functional enhancement” – strains specifically designed to complement different activities and states of mind.
Imagine walking into a dispensary and finding joints specifically designed for different experiences: one for creative work, another for social situations, maybe even one for physical exercise. It’s not just about getting high anymore; it’s about choosing the exact kind of experience you want. The success of GSD’s THCV-dominant profile shows there’s already a market for this kind of targeted effect.
However – and this is a big however – all of this potential remains somewhat constrained by federal prohibition. The current legal landscape is like trying to run a marathon with your shoelaces tied together. The inability to conduct unrestricted research, move products across state lines, or access traditional banking services continues to hold back innovation. Just imagine what companies like Natural Natural could achieve if they had the same freedom to research and develop as other industries.
Despite these challenges, I remain optimistic. The cannabis industry has shown remarkable resilience and creativity even under restrictive conditions. When – not if – federal legalization finally arrives, I believe we’ll see an explosion of innovation that will transform cannabis in ways we can barely imagine today. The cannabis industry of 2030 might be as different from today as today’s legal market is from the underground scene of the 1990s.
One thing’s for certain – we’re living through a fascinating period in cannabis history, and developments like GSD are just the beginning. The future of cannabis isn’t just bright; it’s technicolor.
After spending considerable time analyzing GSD and its implications for the cannabis industry, one thing has become crystal clear to me – we’ve entered a new era of cannabis development. The introduction of scientifically-backed, purpose-bred strains like GSD isn’t just another product launch; it’s a paradigm shift in how we approach cannabis cultivation and development.
When I think back to my early days writing about cannabis, most conversations centered around THC percentages and whether indicas or sativas produced better highs. Now, we’re discussing clinical trials, specific cannabinoid ratios, and targeted effects. It’s like watching a garage band evolve into a symphony orchestra – same basic elements, but infinitely more sophisticated.
As cannabis laws continue to relax (and trust me, they will), we’ll see an influx of bright minds and serious innovation in this space. Combine this with the exponential learning capabilities of AI and advanced genetic research tools, and the potential becomes staggering. We’re talking about new medicines that could revolutionize mental health treatment, recreational products that enhance rather than impair, and industrial applications we haven’t even dreamed of yet.
It’s wild to think that less than a century ago, “Reefer Madness” propaganda was convincing people that cannabis would turn them into murderous fiends. Now, we’re developing strains that help people focus and get work done. The irony isn’t lost on me.
We’re living through what future historians will likely consider the renaissance of cannabis. The development of strains like GSD is just the beginning. As someone who’s dedicated their career to understanding and writing about this remarkable plant, I can tell you – the best is yet to come. Stay tuned, fellow enthusiasts. The cannabis story is just getting good.
NEW CANNABIS STRAIN INFO, READ ON…
You may like
Cannabis News
Colorado Could Become a Global Hub for Marijuana Genetics
Published
15 hours agoon
January 23, 2025By
admin
Ability to source marijuana genetic material from outside Colorado
Senate Bill 23-271, which went into effect in early 2024, aims to enhance Colorado’s marijuana industry. A key provision allows licensed marijuana cultivators to source “genetic material” from approved entities in other jurisdictions. Genetic material is defined as material used to propagate cannabis plants, including:
- Immature plants and small plant fragments with ≤0.3% D9 THC on a dry weight basis;
- Cannabis seeds, which grow into marijuana; and
- Tissue cultures.
This law significantly expands sourcing options for Colorado cultivators, including opportunities, both domestic and international. Colorado cultivators can now bring in popular OG strains from around the world.
The anticipated marketing frenzy, however, hasn’t fully materialized. The answer lies in the complexity of transporting genetics across state and international lines.
That’s where we come in. With years of experience advising clients on compliant cross-border transportation, we understand the nuances in the law. Below is a high-level overview of the challenges involved. If you or your clients are ready to make an impact in Colorado’s market, please reach out to me or my team— we’d be happy to assist.
Marijuana genetics: are they hemp or marijuana?
This question – the Schrödinger’s Cat of the cannabis industry – is both simple and complex. In short, under federal law, marijuana genetics appear to be hemp. However, they are neither strictly hemp nor marijuana until a state makes that determination. In fact, in some states they may be both marijuana and hemp.
- “Marihuana” (referred to in this blog post as “marijuana”) is defined in the Controlled Substances Act (“CSA”), as “all parts of the plant Cannabis sativa L., whether growing or not; the seeds thereof; the resin extracted from any part of such plant; and every compound, manufacture, salt, derivative, mixture, or preparation of such plant, its seeds or resin.”
- Marijuana does not include “hemp” as defined in the Agricultural Improvement Act of 2018 (the “2018 Farm Bill”).
- Hemp is defined as the plant Cannabis sativa L. and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis.
In January 2022, the DEA issued a letter stating that cannabis seeds and other genetic material with ≤0.3% D9 THC meet the definition of hemp and aren’t controlled substances. Importantly, the DEA further clarified in a December 2022 letter that if the cannabis seed germinates into material exceeding 0.3% THC, then “that material” falls within CSA control. DEA’s use of “that material” rather than specifying the seed used to grow “that material” further supports that DEA, at least for now, does not view marijuana genetics (testing at ≤0.3% THC on a dry weight basis) as marijuana.
While these DEA letters aren’t legally binding, they suggest that marijuana genetics, when testing at ≤0.3% D9 THC, are considered hemp under federal law.
State complexities with marijuana and hemp genetics
Since marijuana genetics are currently treated as hemp under federal law, they can move across U.S. state and international lines. However, the 2018 Farm Bill allows states to impose stricter laws.
Some states, like neighboring Arizona, define marijuana genetics as material that will only grow into hemp. Others, like Arkansas, do not expressly exempt “hemp” form the definition of “marijuana,” creating a situation where the genetics are both hemp and marijuana. And States like Mississippi and Minnesota prohibit the sale of cannabis sativa seeds all together.
Understanding both federal and state laws is critical to ensuring a compliant transfer into Colorado. If the exporting state defines the genetics as hemp and permits exports, cultivators can likely import them into Colorado. If the exporting state does not define marijuana genetics as hemp, then selling or transporting marijuana genetics could lead to criminal violations under a state’s marijuana laws.
International considerations
An international import of marijuana genetics must comply with both state, federal, and international laws. As long as the export meets USDA and Customs requirements, federal law typically won’t pose an issue. However, it’s essential to consider the laws of the exporting country, and importing US state, ensuring that the genetics are classified as hemp by both governments. Otherwise, the transport may not only violate a US state’s laws, but also international law.
Conclusion
Licensed Colorado cultivators seeking unique marijuana strains from outside the state—whether from California, Oregon, or countries like Colombia and Jamaica—must navigate both federal and state laws. Harris Sliwoski has extensive experience helping operators transfer cannabis genetics. With our new Denver office, we are ready to assist Colorado cultivators with global genetics imports. A “Tour de Cannabis” anyone?
Cannabis News
America’s Constitutional Conundrum: Guns and Ganja
Published
3 days agoon
January 21, 2025By
admin
Of Guns and Ganja: America’s Constitutional Conundrum
If there’s one thing America is famous for, it’s guns – and lots of ’em! In the land of the free and home of the brave, firearms aren’t just a right, they’re practically a national pastime. With over 400 million firearms floating around a nation of 330 million people, it’s safe to say that guns are as American as apple pie and baseball.
But you know what else Americans love? Drugs. The US remains the world’s largest drug market, with an particularly passionate affair with cannabis. Mary Jane has come a long way since the “Just Say No” propaganda of the D.A.R.E. days. Now, millions of Americans legally light up in their home states, transforming from “criminals” to “consumers” faster than you can say “tax revenue.”
Here’s where things get sticky though. Despite the Biden administration’s vague promises of reform, cannabis remains stubbornly classified as a Schedule I substance at the federal level. This creates a peculiar predicament for freedom-loving Americans who appreciate both their Second Amendment rights and their evening toke.
You see, there’s this obscure interpretation of federal law that says if you consume cannabis – even legally in your state – you’re technically not allowed to own firearms. Let that sink in for a moment: in a country with more guns than people, where cannabis is legally sold in most states, you’re forced to choose between your constitutional right to bear arms and your state-sanctioned right to consume a plant.
As you might imagine, telling Americans they can’t have their guns AND their ganja isn’t exactly going over well. It’s a uniquely American saga that pits state rights against federal law, personal freedom against bureaucratic overreach, and common sense against, well… whatever you’d call this situation.
Let’s dive into this bizarre legal battleground where constitutional rights and cannabis collide.
As America’s cannabis landscape evolves, we’re witnessing a fascinating legal tug-of-war between state sovereignty and federal authority. The latest battleground? The constitutional rights of cannabis consumers to bear arms.
In a groundbreaking decision, the U.S. Court of Appeals for the Fifth Circuit recently reaffirmed that banning occasional marijuana users from owning firearms is unconstitutional. The case, known as U.S. v. Daniels, centers around a man who was sentenced to four years in prison after police found trace amounts of cannabis and firearms during a routine traffic stop. Talk about wrong place, wrong time!
The federal government, particularly under the Biden administration, has been performing some impressive mental gymnastics to justify their position. Their argument? Cannabis users with guns “endanger public safety,” “pose a greater risk of suicide,” and are more likely to commit crimes “to fund their drug habit.” They’ve even argued that cannabis consumers are “unlikely to store their weapons properly.” I guess they never met my ex-military uncle who meticulously organizes his gun safe while enjoying his evening edible.
But here’s where it gets really interesting. The Department of Justice claims the restriction is perfectly constitutional because it aligns with the nation’s history of disarming “dangerous” individuals. They’re essentially putting cannabis users in the same category as folks with domestic violence restraining orders. As someone who’s spent considerable time around both cannabis users and domestic abusers (professionally, of course), I can tell you there’s a slight difference in temperament.
The courts, however, aren’t buying it. As the Fifth Circuit pointed out, the government failed to prove that Daniels was “presently or even regularly intoxicated at the time of arrest.” They noted that even if the government had proven frequent intoxication, they offered “no Founding-era law or practice of disarming ordinary citizens ‘even if their intoxication was routine.'”
The ruling doesn’t completely invalidate the federal statute (known as § 922(g)(3)), but it does expose its shaky constitutional foundation. As the court stated, “This is not a windfall for defendants charged under § 922(g)(3),” but rather a recognition that the government’s enforcement approach is fundamentally flawed.
Meanwhile, the National Rifle Association (NRA) – not exactly known for their progressive stance on substances – acknowledges the absurdity of the situation. They point out that “marijuana use is no longer limited to the domain of indigenous religious customs or youth-oriented counterculture and now includes a wide variety of people who use it for medicinal or recreational reasons.” When even the NRA is suggesting your gun control measure might be a bit extreme, you know something’s amiss.
The result of all this legal wrangling? A patchwork of confusion where state-legal cannabis users must choose between their Second Amendment rights and their medicine or recreational preference. It’s a prime example of how federal prohibition creates more problems than it solves, forcing otherwise law-abiding citizens to become unwitting criminals simply for exercising multiple legal rights simultaneously.
Welcome to America, folks, where you can have your guns or your ganja, but apparently not both – at least until the courts finish sorting out this constitutional cannabis conundrum.
Let me be blunt – we’re caught in a classic American political pretzel. The Biden administration dangles the carrot of rescheduling cannabis to Schedule III, making vague promises that sound good on the campaign trail but do little to address the fundamental issues plaguing cannabis consumers, including their right to bear arms.
While some celebrate these baby steps toward reform, I’ve been around this block enough times to know that rescheduling is like putting a Band-Aid on a bullet wound. It might stop some bleeding, but it doesn’t address the underlying trauma. The gun rights issue is just one of many complications that arise from cannabis’s continued inclusion in the Controlled Substances Act (CSA).
Here’s the uncomfortable truth: there’s only one real solution, and it runs straight through the halls of Congress. The same body that created this mess with the CSA in 1971 is the only one with the power to truly fix it. Congress needs to completely remove cannabis from the CSA – not reschedule it, not modify its status, but fully deschedule it.
Think about it. Rescheduling to Schedule III would still leave cannabis in a weird legal limbo. Sure, it might make research easier and give Big Pharma more room to play, but what about the millions of Americans who use cannabis medicinally or recreationally in their state-legal markets? They’d still be federal criminals, still banned from purchasing firearms, still caught in the crossfire between state and federal law.
The only path forward is complete removal from the CSA, coupled with a federal framework that respects state markets while establishing basic national standards. This would resolve the gun rights issue overnight – no more choosing between your Second Amendment rights and your medicine or recreational preference.
Would I love to see Congress completely overhaul the CSA? Absolutely. The entire scheduling system is based on outdated science and political theater rather than actual harm reduction principles. But let’s be realistic – that’s about as likely as finding bipartisan agreement on… well, anything these days.
Instead, we need to focus on what’s achievable: complete cannabis descheduling. This isn’t just about guns and ganja – it’s about fixing a broken system that’s created countless legal paradoxes and unnecessary criminal penalties. It’s about acknowledging that the emperor has no clothes, that cannabis prohibition has failed, and that it’s time to move forward with a sensible federal policy.
Until Congress acts, we’ll continue to see these legal battles play out in courts across the country, watching judges try to reconcile constitutional rights with outdated federal drug laws. It’s a waste of judicial resources, taxpayer money, and most importantly, it’s a waste of Americans’ time and freedom.
The solution is clear. The only question is: how many more Americans need to get caught in this legal crossfire before Congress finally does its job?
Inspiration:
https://www.marijuanamoment.net/federal-court-reaffirms-that-ban-
on-gun-ownership-for-people-who-occasionally-use-marijuana-is-unconstitutional/
https://www.marijuanamoment.net/nra-says-federal-ban-on-
marijuana-amid-state-level-legalization-has-created-confusing-legal-landscape-for-gun-owners/
CANNABIS AND GUN RIGHTS, READ ON…
Cannabis News
MLK Day 2025: Cannabis and Civil Rights
Published
4 days agoon
January 20, 2025By
admin
It’s MLK Day once again.
I’ve been writing an MLK Day post on this blog for eight consecutive years. The theme of my posts is that cannabis is a civil rights issue, and that Dr. King would have advocated for ending prohibition based on that fact.
Each year, I have demonstrated with facts (upon facts upon facts) that the War on Drugs continues in insidious ways. In, 2023, which is the most recent year that FBI data is available, law enforcement officials made over 200,000 arrests for marijuana-related convictions. Those 200,000 arrests constitute roughly 25% of all drug-related arrests.
Sadly, arrests of black people constituted 29% of all drug arrests in 2023, although only 13.6% of Americans are black.
Heading into MLK Day weekend, President Biden announced that he is commuting the sentences of nearly 2,500 people convicted of non-violent drug offenses. The focus was predominantly on individuals “who received lengthy sentences based on discredited distinctions between crack and powder cocaine…”, as opposed to cannabis-related crimes. According to the Last Prisoner Project, “the total number of those incarcerated for cannabis who received commutations is not knows, but nine LPP constituents will be free.”
For all that Biden promised as to cannabis, it’s the least we could have asked. Under the new Trump administration, attention will quickly return to the frustrating marijuana rescheduling process. If cannabis ends up on Schedule III, criminal penalties for traffickers may soften, but make no mistake: possessing and distributing cannabis will still be a federal crime.
At the state level, where most arrest occur, progress has slowed in the last few years. Out here where I live in Oregon, with our 800 cannabis stores, it’s astonishing to think of 200,000 annual cannabis arrests– most for simple possession, no less.
There is a lot of work to do. Here are a short list of organizations if you’d like to get involved:
For prior posts in this series:
Try This Marijuana Infused Cassava Cake
Joe Rogan Continues To Champion Cannabis
Colorado Could Become a Global Hub for Marijuana Genetics
Leafly Buzz: 12 hottest weed strains to smoke in 2025
Can Medical Cannabis Help Support Immune Health?
TikTok’s Double Standard on Marijuana And Alcohol
President Trump will decide marijuana rescheduling, federal reform
Are These the Top Cannabis Dispensaries In New York?
Panama And Cannabis
LA’s cannabis community steps up for wildfire relief
Distressed Cannabis Business Takeaways – Canna Law Blog™
United States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
What you Need to Know
Drug Testing for Marijuana – The Joint Blog
NCIA Write About Their Equity Scholarship Program
It has been a wild news week – here’s how CBD and weed can help you relax
Cannabis, alcohol firm SNDL loses CA$372.4 million in 2022
A new April 20 cannabis contest includes a $40,000 purse
Your Go-To Source for Cannabis Logos and Designs
UArizona launches online cannabis compliance online course
Trending
-
Cannabis News2 years ago
Distressed Cannabis Business Takeaways – Canna Law Blog™
-
One-Hit Wonders2 years ago
United States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
-
Cannabis 1012 years ago
What you Need to Know
-
drug testing1 year ago
Drug Testing for Marijuana – The Joint Blog
-
Education2 years ago
NCIA Write About Their Equity Scholarship Program
-
Cannabis2 years ago
It has been a wild news week – here’s how CBD and weed can help you relax
-
Marijuana Business Daily2 years ago
Cannabis, alcohol firm SNDL loses CA$372.4 million in 2022
-
California2 years ago
A new April 20 cannabis contest includes a $40,000 purse